Premium
Proteasome inhibitor‐associated thrombotic microangiopathy: A review of cases reported to the FDA adverse event reporting system and published in the literature
Author(s) -
Nguyen Michelle Nadeau,
Nayernama Afrouz,
Jones S. Christopher,
Kanapuru Bindu,
Gormley Nicole,
Waldron Peter E.
Publication year - 2020
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25832
Subject(s) - thrombotic microangiopathy , medicine , adverse effect , adverse event reporting system , proteasome inhibitor , intensive care medicine , pharmacology , multiple myeloma , disease